Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Product › Details

Aubagio®

	Next higher product group	teriflunomide
	Status	2012-09-12 registration start
	Organisation	Sanofi-Aventis (Group)
	Group	Sanofi (Group) [since May 2011]
	Organisation 2	Aventis Pharmaceuticals Inc.
	Group	Sanofi (Group) [since May 2011]

Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for immuno modulatory compound (IMO)_o

[1] Immunic, Inc.. (3/16/22). "Press Release: Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial Officer". New York, NY....
[2] Immunic, Inc.. (10/14/21). "Press Release: Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer". New York, NY....
[3] Targovax ASA. (3/7/22). "Press Release: Targovax ASA and Agenus Announce Collaboration on Mutant KRAS Cancer Vaccine Adjuvanted with QS-21 STIMULON". Oslo....
[4] Immunic, Inc.. (2/26/21). "Press Release: Immunic, Inc. Reports Year End 2020 Financial Results and Highlights Recent Activity". New York, NY....
[5] Sanofi S.A.. (9/28/20). "Press Release: Sanofi Completes Principia Biopharma Inc. Acquisition. Principia Biopharma Inc. Is Now a Wholly Owned Subsidiary of Sanofi". Paris....
[6] Sanofi S.A.. (8/17/20). "Press Release: Sanofi to Acquire Principia Biopharma". Paris & South San Francisco, CA....
[7] Immunic, Inc.. (1/8/20). "Press Release: Immunic Exercises its Option for the Exclusive Worldwide License to IMU-856 from Daiichi Sankyo Co., Ltd.". New York, NY....
[8] ImmuPharma plc. (12/19/19). "Press Release: ImmuPharma Lists on Euronext Growth Brussels". Brussels....
[9] Asahi Kasei Corporation. (11/25/19). "Press Release: Presentation – Accelerating Transformation into a Global Health Care Company. Acquisition of U.S.-based Veloxis Pharmaceuticals Inc.". Tokyo....
[10] Veloxis Pharmaceuticals A/S. (11/25/19). "Press Release: Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis [Not for any jurisdiction where violation of law]". Copenhagen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]